Reema Bhushan

Clinicopathological Implications of IDH1 Mutation and Ki-67 Expression Across WHO Grades of Gliomas: Insights from a Prospective Observational Study.

Background & Objective: Gliomas are heterogeneous central nervous system tumors with variable outcomes. Accurate classification using histopathological and molecular markers, such as IDH1 R132H mutation and Ki-67 index, is essential. This study evaluated their distribution across...